Cargando…
CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A)
(1) Background: Acute administration of the cannabinoid receptor 1 (CB1R) inverse agonist Rimonabant (SR141716A) to fed Wistar rats was shown to elicit a rapid and short-lasting elevation of serum free fatty acids. (2) Methods: The effect of Rimonabant on lipolysis in isolated primary rat adipocytes...
Autores principales: | Müller, Günter A., Herling, Andreas W., Wied, Susanne, Müller, Timo D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070561/ https://www.ncbi.nlm.nih.gov/pubmed/32085406 http://dx.doi.org/10.3390/molecules25040896 |
Ejemplares similares
-
Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiation
por: Murumalla, Ravi, et al.
Publicado: (2011) -
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
por: Ciaglia, Elena, et al.
Publicado: (2015) -
The CB(1) Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
por: Gueye, Aliou B., et al.
Publicado: (2016) -
Effects of SR141716A on Cognitive and Depression-Related Behavior in an Animal Model of Premotor Parkinson's Disease
por: Tadaiesky, M. T., et al.
Publicado: (2010) -
The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling
por: Ruz-Maldonado, Inmaculada, et al.
Publicado: (2020)